FDA DEVICE FACTS
GYNECARE TVT Abbrevo Continence System; GYNECARE TVT Obturator Continence System
ETHICON, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The GYNECARE TVT ABBREVO™ Helical Passers and Atraumatic Winged Guide are intended to aid in the placement of the GYNECARE TVT ABBREVO™ device.
The GYNECARE TVT™ Obturator Helical Passers and Atraumatic Winged Guide are intended to aid in the placement of the GYNECARE TVT™ Obturator device.
The GYNECARE TVT ABBREVO™ Continence System is intended for use in women as a suburethral sling for the treatment of stress urinary incontinence (SUI) resulting from urethral hypermobility and/or intrinsic sphincter deficiency.
The GYNECARE TVT Obturator device is intended to be used in women as a sub-urethral sling for the treatment of stress urinary incontinence (SUI) resulting from urethral hypermobility and/or intrinsic sphincter deficiency.
Operating principle Aid in the placement of surgical mesh Treatment of women with stress urinary incontinence Treatment of women with stress urinary incontinence Patient contact durations < 24 hours (tissue/bone) Permanent (tissue/bone) Permanent (tissue/bone) Device Design Instrumentation Mesh Mesh Device Materials Stainless steel, polycarbonate Woven polypropylene Woven polypropylene
The indications for use statements for the subject device and the predicate device are not identical, as the predicate device is a surgical mesh that is indicated for stress urinary incontinence. The intended use of the subject and predicate device is the same, as the subject device is an accessory to a surgical mesh.
As described in the table above, the operating principle, patient contact, device design, and device materials are different between the subject and predicate devices. The predicate device is a surgical mesh, whereas the subject devices are used for the placement of surgical mesh. The differences between the subject and predicate device can raise different questions of safety and effectiveness, as we are comparing an accessory and parent device. However, the subject devices are accessories to the predicate devices. The differences in technological characteristics were evaluated through completion of special controls (performance testing, biocompatibility, shelf-life/reprocessing, labeling, and sterilization) published in the final order reclassifying urogynecologic surgical mesh instrumentation from class I to class II published on January 6, 2017.
Summary of Performance Testing
The following performance tests were completed on the subject devices:
• Sterilization validation
• Package integrity
• Dimensional and mechanical performance
• Biocompatibility o Cytotoxicity o Sensitization o Irritation
• Shelf life
The results of performance testing demonstrate the subject devices are sterile to an SAL for 10-6, biocompatible, have sufficient mechanical performance for their intended use, and have a validated shelf life.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。